对多发性骨髓瘤和骨髓纤维化进行全源干细胞移植,分剂量使用布苏尔,弗鲁达拉宾和环胺
Andrew D Trunk1, Sagar S Patel1, Josef T Prchal1
1Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, USA.
Leukemia research reports
|September 13, 2023
概括
这项研究探讨了用于髓纤维化和多发性髓瘤的新干细胞移植方案. 这种新的方法显示出有希望的生存率和持久的缓解,这表明对这些具有挑战性的条件的安全性有所改善.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 移植医学 移植医学 移植医学
背景情况:
- 异构干细胞移植 (SCT) 与骨髓纤维化 (MF) 和多发性骨髓瘤 (MM) 患者的显著发病率和死亡率有关.
- 标准的骨髓损伤疗法对这些患者群体构成相当大的风险.
研究的目的:
- 评估一种新型肌肉衰变调节方案的安全性和有效性,用于MF和MM患者的全源性SCT.
- 评估关键结果,包括非复发性死亡率,整体存活率和移植与宿主疾病 (GVHD).
主要方法:
- 进行了2期临床试验,招募了患有MF和MM的患者.
- 进行了一种新型的骨髓损伤疗法,包括分剂量布苏尔,弗鲁达拉宾和移植后的环胺.
- 结果在移植后1年被评估,并进行长期随访.
主要成果:
- 该研究招募了4名MF患者和2名MM患者.
- 一年后,非复发性死亡率为33.3%,总生存率为50%.
- 急性GVHD发生率为33.3%,慢性GVHD发生率为16.7%.
结论:
- 这种新型调节方案在这个小群体中显示出相对安全性.
- 观察到有利的关键结果,包括长期幸存者的持久缓解.
- 这种方法可能为MF和MM患者的全基性SCT提供一个可行的替代方案.
相关概念视频
Bone Marrow Sampling and Transplants
356
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
356
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K


